Trimeris.com
Trimeris is ranked > 3,000,000 in the United Kingdom. 'Orphan Drug Development, LAL Deficiency, Synageva BioPharma Company.'
--Rank in United Kingdom
--Worldwide Rank
| Monthly pages viewed | < 300 | |
| Monthly visits | < 300 | |
| Value per visitor | -- | |
| Estimated worth | £265.5 | |
| External links | 132 | |
| Number of pages | 90 |
Last Updated: 05/04/2018 . Estimated data, read disclaimer.
Content
www.Trimeris.com
Topics: Management Team, Board Of Directors, Directions, and Why Synageva.
Category: 'Biopharmaceuticals/Research and Development'
Age: The domain is 20 years and 9 months old.
- Popular pages
- trimeris.com Strategic Alliances
- trimeris.com Fuzeon
- trimeris.com Next Generation Fusion Inhibitor
- trimeris.com Contact Us
- Links out
- clinicaltrials.gov Home - ClinicalTrials.gov
- poz.com POZ - POZ Magazine - POZ.com - HIV - AIDS - HIV AIDS
- thebody.com The Complete HIV/AIDS Resource - The Body
- amfar.org amfAR, The Foundation for AIDS Research
The programming language environment is ASP.NET. There are 4 DNS records, such as yns2.yahoo.com, ns8.san.yahoo.com, and ns9.san.yahoo.com.
IP: 97.65.235.117
Powered by: ASP.NET
Web Server: Microsoft-IIS/7
Encoding: utf-8
| Server Setup | |
| Cache-Control: | private |
|---|---|
| Content-Length: | 30374 |
| Content-Type: | text/html; charset=utf-8 |
| Server: | Microsoft-IIS/7.5 |
| Set-Cookie: | -- |
| X-Powered-By: | ASP.NET |
| Date: | -- |